Dev Chatterjee

Founder & CEO

CEO of Goldenrod Therapeutics. Leads development of the 11h PDE4 inhibitor program targeting Friedreich's Ataxia and neurodegenerative indications.

Overview

Companies
1
Roles
Founder & CEO

Companies

1 company
Goldenrod Therapeutics $7M
Private Founder & CEO

Founder data is compiled from company records, public announcements, and verified sources. Roles reflect current or most recent known positions.